Literature DB >> 29332084

Thalamic Deep Brain Stimulation.

Benjamin B Whiting, Alexander C Whiting, Donald M Whiting.   

Abstract

The use of deep brain stimulation (DBS) of the thalamus has been proven to be a safe and efficacious treatment for the management of many diseases. The most common indication for thalamic DBS remains essential tremor (ET), one of the most common movement disorders in the world. ET patients should be considered for surgical intervention when their tremor has demonstrated to be refractory to medication, a characteristic estimated to be present in roughly 50% of ET cases. Advantages of DBS over thalamotomy include its reversibility, the ability to adjust stimulation settings to optimize efficacy and minimize side effects, the ability to perform bilateral procedures safely, and an association with a lower risk of postoperative cognitive problems. The most common target of DBS for ET is the ventralis intermedius (VIM) of the thalamus, and the optimal electrode location corresponds to the anterior margin of the VIM. Other indications for thalamic DBS include non-ET tremor, obsessive-compulsive disorder, neuropathic pain, traumatic brain injury, Tourette's syndrome, and drug-resistant epilepsy among others.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2018        PMID: 29332084     DOI: 10.1159/000481104

Source DB:  PubMed          Journal:  Prog Neurol Surg        ISSN: 0079-6492


  6 in total

1.  Precision mapping of the epileptogenic network with low- and high-frequency stimulation of anterior nucleus of thalamus.

Authors:  Ganne Chaitanya; Emilia Toth; Diana Pizarro; Auriana Irannejad; Kristen Riley; Sandipan Pati
Journal:  Clin Neurophysiol       Date:  2020-06-30       Impact factor: 3.708

Review 2.  Medical and Surgical Treatment for Medication-Induced Tremor: Case Report and Systematic Review.

Authors:  Wardell E Amerika; Saskia van der Gaag; Arne Mosch; Niels A van der Gaag; Carel F E Hoffmann; Rodi Zutt; Johan Marinus; Maria Fiorella Contarino
Journal:  Mov Disord Clin Pract       Date:  2022-05-24

3.  Case report: Improved behavioral and psychiatric symptoms with repetitive transcranial magnetic stimulation at the bilateral DLPFC combined with cognitive and behavioral therapy in a patient with unilateral thalamic hemorrhage.

Authors:  Hye Chan Ahn; Kyoung Tae Kim
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

Review 4.  The Management of Poststroke Thalamic Pain: Update in Clinical Practice.

Authors:  Songjin Ri
Journal:  Diagnostics (Basel)       Date:  2022-06-10

5.  Bilateral Posterior Subthalamic Area Deep Brain Stimulation for Essential Tremor: A Case Series.

Authors:  Xiaoyu Sun; Luke Huang; Yixin Pan; Chencheng Zhang; Tao Wang; Hongxia Li; Bomin Sun; Jianqing Ding; Yiwen Wu; Dianyou Li
Journal:  Front Hum Neurosci       Date:  2020-02-05       Impact factor: 3.169

6.  TCF7L2 regulates postmitotic differentiation programmes and excitability patterns in the thalamus.

Authors:  Marcin Andrzej Lipiec; Joanna Bem; Kamil Koziński; Chaitali Chakraborty; Joanna Urban-Ciećko; Tomasz Zajkowski; Michał Dąbrowski; Łukasz Mateusz Szewczyk; Angel Toval; José Luis Ferran; Andrzej Nagalski; Marta Barbara Wiśniewska
Journal:  Development       Date:  2020-08-25       Impact factor: 6.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.